Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Jan:166:133-136.
doi: 10.1016/j.radonc.2021.11.013. Epub 2021 Nov 25.

The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial

Cindy S Ortiz  1 , Diana Hernández  2 , Cesar Trujillo  2 , David Calderón  1 , Placido Esqueda  1 , Flavio Calva  3 , Arcadio Betancourt  3 , Miriam Ramírez  1 , Graciela Cervantes  1 , Miguel A Souto  4 , Juan G Celis  5 , Luis R Nolazco  5 , Alejandro Olmos  6
Affiliations
Clinical Trial

The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial

Cindy S Ortiz et al. Radiother Oncol. 2022 Jan.

Abstract

This is a paired prospective comparative cohort study with 58 patients, in order to analyze the clinical LD-WLI in patients with moderate or severe COVID19 pneumonia. The results of this study show that the Radiotherapy could be an option to improve the clinical response for patients with COVID-19.

Keywords: Acute respiratory distress syndrome (ARDS); COVID-19; Low dose radiotherapy (LDRT); SARS-CoV2.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Survival analysis of patients with COVID-19 pneumonia treated with or without radiotherapy. (A) Moderate and severe ARDS patients. (B) Moderate ARDS patients. C) Severe ARDS patients.
See this image and copyright information in PMC

Comment in

References

    1. Baud D., Qi X., Nielsen-Saines K., Musso D., Pomar L., Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20:773. - PMC - PubMed
    1. Organización Mundial de la salud. Manejo clínico de la infección respiratoria aguda grave (IRAG) en caso de sospecha de COVID-19. Última revisión 09/05/2020. Recuperado de: https://apps.who.int/iris/bitstream/handle/10665/331660/WHO-2019-nCoV-cl....
    1. Palacios Cruz M., Santos E., Velázquez Cervantes M.A., León Juárez M. COVID-19, una emergencia de salud pública mundial. RevClinEsp. 2021;221:55–61. - PMC - PubMed
    1. Rödel F., Arenas M., Ott O.J., Fournier C., Georgakilas A.G., Tapio S., et al. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlenttheronkol. 2020;196:679–682. - PMC - PubMed
    1. Powell E.V. Roentgen therapy of lobar pneumonia. J Am Med Assoc. 1938;110:19–22.

Publication types